Availability of lower-priced epinephrine auto-injectors did not solve the affordability problem for all patients with severe allergies

By | July 12, 2022
People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen was the primary option, a new study shows.